{"commentary":{"count":17,"free_build_floor":8,"listing_floor":3,"by_channel":{"youtube":8,"podcast":7,"x_thread":2},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT04762953\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's public preview; the full report is still bought."},"name":"STOPGAP","nct_id":"NCT04762953","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=stopgap-nct04762953. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 13–40 commentary sources"},"registry":{"acronym":"STOPGAP","arms":[{"description":"Patients will receive sequential intraperitoneal paclitaxel along with intravenous paclitaxel, 5-FU, and leucovorin on Days 1 and 8 of every 21 day cycle for 3 months.","label":"SingleArm: Systemic therapy and IP Paclitaxel in Gastric/GEJ Cancer Peritoneal Carcinomatosis","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2026-12","type":"ESTIMATED"},"conditions":["Gastric Cancer","Peritoneal Carcinomatosis","Gastroesophageal Junction Adenocarcinoma"],"enrollment":{"count":40,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Paclitaxel","type":"DRUG"},{"name":"Paclitaxel","type":"DRUG"},{"name":"Leucovorin","type":"DRUG"},{"name":"Fluorouracil","type":"DRUG"}],"last_update":"2026-02-03","lead_sponsor":"University of California, Irvine","official_title":"Phase II Trial of Sequential Systemic Therapy Plus Intraperitoneal Paclitaxel in Gastric/GEJ Cancer Peritoneal Carcinomatosis (STOPGAP)","overall_status":"ACTIVE_NOT_RECRUITING","phases":["PHASE2"],"primary_completion_date":{"date":"2026-12","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Participants with Progression Free Survival at 1-Year","timeFrame":"1 year"},{"measure":"Incidence of Treatment-Emergent Adverse Events [Safety]","timeFrame":"From date of study treatment initiation to first date of disease progression, toxicity, delay of treatment, or withdrawal of treatment, assessed up to 12 months after the last patient is enrolled."}],"references":[{"citation":"Senthil M, Dayyani F. Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial. BMC Cancer. 2023 Mar 4;23(1):209. doi: 10.1186/s12885-023-10680-1.","pmid":"36870941","type":"DERIVED"}],"start_date":{"date":"2021-02-18","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal Carcinomatosis","url":"https://clinicaltrials.gov/study/NCT04762953"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/stopgap-nct04762953"}